Novartis Jacked Up Painkiller Prices, Class Action Claims

Law360, Los Angeles (January 2, 2014, 7:40 PM EST) -- Novartis AG was hit with a proposed consumer class action in New Jersey federal court Tuesday claiming the Swiss pharmaceutical giant sells a popular over-the-counter migraine medication at a higher price than an identical product marketed under a different name.

Named plaintiff Kerri Yingst alleges that Novartis sells the painkiller Excedrin Migraine at a higher price than Excedrin Extra Strength, which has an identical formulation and dosage. Yingst, of Cherry Hill, N.J., bought Excedrin Migraine repeatedly during the past eight years to treat her recurrent migraines,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.